ד"ר אלדד רחביה

Director of Cardiac Intensive Care Unit,

Hasharon Hospital, Rabin Medical Center

1983 - MD diploma; Tel Aviv University Sackler School of Medicine, Israel.

1983 - Internship; Sheba medical Center, Tel Hashomer, Israel, affiliated to the Tel Aviv University Sackler School of Medicine.

1983 - 1985 - Resident, Internal Medicine, Rabin Medical Center, Israel, affiliated to the Tel Aviv University Sackler School of Medicine.

1985 - 1988 - Fellowship in Cardiology, Rabin Medical Center.

1986 - 1988 - Postgraduate studies in Cardiology, Sackler School of Medicine, Tel Aviv University.

7/1988 - 12/1988 - Research Fellowship, Medical Research Council, Royal Postgraduate medical School, Hammersmith Hospital, London, UK.

Basic science thesis: The Detection of Viable Tissue in the Reperfused Dysfunctional Myocardium Assessed by Positron Emission Tomography. Supervisor: Prof. Attilio Maseri, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

1989 - Cardiovascular Division, Hammersmith Hospital, London, UK.

1990 - Passed Specialty Board Examination in Cardiology; Attending Physician, Cardiology Department, Rabin Medical Center.

1993 - 1996 - Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA. Clinical and Research Fellowship in Interventional Cardiology

Since 1/1996 - Attending Physician, Cardiovascular Division and Cardiac Catheterization Unit, Rabin Medical Center.

Since 11/1999 - Director of ICCU and In charge Cardiology Department,

“Golda Campus” Hasharon, Rabin Medical Center.

Since 1986 – Lieutenant Colonel, Israel Defense Air Force.

Professional Organizations:

Member of the Israel Medical Association

Member of the Israel Heart Society

Reviewer for the: European Heart Journal; The Journal of the American College of Cardiology; American Heart Journal; Journal Catheterization and Cardiov

ascular Diagnosis.

List of Publications (since 2008)

60. Kornowski R, Vaknin-Assa H, Lev E, Ben Dor I, Teplitsky I, Rechavia E, Brosh D, Fuchs S, Assali A.

Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation myocardial infarction.

Acute Card Care 2008;10(3):167-172.

61. Fuchs S, Kornowski R, Teplitsky I, Brosh D, Lev E, Vaknin-Assa H, Ben Dor I, Iakobishvili Z, Rechavia E, Battler A, Assali A.

Major bleeding complicating contemporary primary percutaneous coronary interventions - incidence, predictors, and prognostic implications.

Cardiovasc Revasc Med 2009; 10(2):88-93.

62. Minha S, Bental T, Assali A, Vaknkn-Assa H, Lev EI, Rechavia E, Battler A, Kornowski R.

A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients.

Cathet Cardiovasc Interv 2011; 78(5):710-717.

63. Minha S, Kornowski R, Vaknin-Assa H, Dvir D, Rechavia E, Teplitsky I, Brosh D, Bental T, Shor N, Battler A, Lev E, Assali A.

The impact of intracoronary thrombus aspiration on STEMI outcomes.

Cardiovasc Revasc Med 2012; 13(3):167-171.

64. Codner P, Vaduganathan M, Rechavia E, Iakobishvili Z, Greenberg G, Assali A, Hasdai D, Battler A, Kornowski R, Lev E.

Clopidogrel response up to six months after acute myocardial infarction.

Am J Cardiol 2012;110(3):321-325.

65. Perl L, Netzer A, Rechavia E, Bental T, Codner P, Assali A, Mager A, Battler A, Kornowski R, Lev EI.

Long-term outcome of patients with APLA syndrome who undergo percutaneous coronary intervention.

Cardiology 2012;122:76-82.